Secondary Hodgkin Lymphoma and MDS after Paclitaxel-Carboplatin Treatment in a Patient with Small Cell Lung Cancer

被引：0
|
作者：
Petrushevska, Marija [1 ]
Stavrdis, Irina Panovska [2 ]
Petrusevska, Gordana [3 ]
机构：
[1] Inst Preclin & Clin Pharmacol & Toxicol, Fac Med, Skopje, North Macedonia
[2] Univ Clin Hematol, Skopje, North Macedonia
[3] Inst Pathol, Fac Med, Skopje, North Macedonia
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2017年 / 17卷
关键词：
D O I：
10.1016/j.clml.2017.07.129
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
HL-130
引用
收藏
页码：S322 / S323
页数：2
相关论文
共 50 条
  • [1] Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer
    Sandler, Alan
    Gray, Robert
    Perry, Michael C.
    Brahmer, Julie
    Schiller, Joan H.
    Dowlati, Afshin
    Lilenbaum, Rogerio
    Johnson, David H.
    NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (24): : 2542 - 2550
  • [2] Treatment of non small cell lung cancer with Paclitaxel/Carboplatin
    Budinger, M
    Klein, H
    Welte, T
    2ND INTERNATIONAL CONGRESS ON LUNG CANCER, 1996, : 481 - 485
  • [3] Paclitaxel, carboplatin, and oral etoposide in the treatment of small cell lung cancer
    Greco, FA
    Hainsworth, JD
    SEMINARS IN ONCOLOGY, 1996, 23 (06) : 7 - 10
  • [4] Paclitaxel/carboplatin in the treatment of non-small-cell lung cancer
    Belani, CP
    ONCOLOGY-NEW YORK, 1998, 12 (01): : 74 - 79
  • [5] Secondary leukemia after treatment with paclitaxel and carboplatin in a patient with recurrent ovarian cancer
    See, HT
    Thomas, DA
    Bueso-Ramos, C
    Kavanagh, J
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2006, 16 : 236 - 240
  • [6] Long-Term Results of a Phase II Trial of Induction Paclitaxel-Carboplatin Followed by Concurrent Radiation Therapy and Weekly Paclitaxel and Consolidation Paclitaxel-Carboplatin in Stage III Non-small Cell Lung Cancer
    Casas, Francesc
    Vinolas, Nuria
    Ferrer, Ferran
    Agusti, Carles
    Sanchez, Marcelo
    Maria Gimferrer, Josep
    Lomena, Francisco
    Campayo, Marc
    Jeremic, Branislav
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (01) : 79 - 85
  • [7] Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer (vol 355, pg 2542, 2006)
    Sandler, A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (03): : 318 - 318
  • [8] Gemcitabine-paclitaxel-carboplatin (PCG) versus paclitaxel-carboplatin (PC) in advanced non-small cell lung cancer (NSCLC): Quality of life (QOL) analysis
    Oniga, F.
    Paccagnella, A.
    Luise, A.
    Biason, R.
    Ghi, M. G.
    Gatti, C.
    Nascimben, O.
    Mastromauro, C.
    Medici, M.
    D'Amanzo, P.
    Carnuccio, R.
    McMahon, L.
    ANNALS OF ONCOLOGY, 2006, 17 : XI19 - XI19
  • [9] Combination therapy with carboplatin and paclitaxel for small cell lung cancer
    Mouri, Atsuto
    Yamaguchi, Ou
    Miyauchi, Sachiko
    Shiono, Ayako
    Utsugi, Harue
    Nishihara, Fuyumi
    Murayama, Yoshitake
    Kagamu, Hiroshi
    Kobayashi, Kunihiko
    RESPIRATORY INVESTIGATION, 2019, 57 (01) : 34 - 39
  • [10] Phase II study of paclitaxel-carboplatin (PC) weekly combination chemotherapy in advanced non small cell lung cancer (NSCLC).
    Cerny, T
    D'Addario, G
    Morant, R
    ANNALS OF ONCOLOGY, 2000, 11 : 118 - 118
12345